Enrolling by Invitation
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection
NCT07149454
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +3 more
- Locations
-
- Lanzhou Institute of Biological Products Co., Ltd. Lanzhou, Gansu, China